Cytokines, the Acute-Phase Response, and Resting Energy Expenditure in Cachectic Patients with Pancreatic Cancer
- 1 April 1994
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Annals of Surgery
- Vol. 219 (4), 325-331
- https://doi.org/10.1097/00000658-199404000-00001
Abstract
To determine whether resting energy expenditure (REE) is increased in cachectic patients with pancreatic cancer and to define the relation of tumor necrosis factor (TNF) and interleukin-6 (IL-6) production to the acute-phase response and to REE. Measurement of REE (indirect calorimetry) and assessment of body composition (bioelectrical impedance analysis) were done in 21 patients with unresectable pancreatic cancer and on 16 age-related controls. The systemic inflammatory response in peripheral blood of the cancer patients was assessed using the acute-phase protein, C-reactive protein, and the cytokines TNF and IL-6. Production of these cytokines by peripheral blood mononuclear cells in vitro was also measured. Patients with pancreatic cancer had an elevated REE when compared with controls (73.4 +/- 5.0 vs. 53.5 +/- 1.6 kcal/kg body cell mass; p < 0.003). Resting energy expenditure was significantly greater in cancer patients with an acute-phase response (C-reactive protein > 10 mg/L) than in those who did not have such a response (85.5 +/- 10.0 [n = 9] vs. 64.3 +/- 3.0 [n = 12] kcal/kg body cell mass; p < 0.04). Tumor necrosis factor was not detected in the serum of any of the cancer patients. Serum IL-6 was detected but levels were not significantly different among cancer patients with or without an acute-phase response. In contrast, spontaneous production of TNF and IL-6 by isolated peripheral blood mononuclear cells was significantly greater in cancer patients with an acute-phase response that in those without (TNF: 1231 +/- 244 vs. 210 +/- 54 pg/ml/10(5) cells; p < 0.001; IL-6: 11.5 +/- 1.7 vs. 3.6 +/- 1.4 ng/mL/10(5) cells; p < 0.003). In pancreatic cancer at least a component of weight loss is due to increased REE. Furthermore, the presence of an acute-phase response identifies a group of patients who are markedly hypermetabolic. The serum concentration of TNF of IL-6 does not correlate with the presence of an acute-phase response, whereas rates of cytokine production by peripheral blood mononuclear cells are significantly greater in patients with such a response. This suggests that local rather than systemic cytokine production may be important in regulating the acute-phase response.Keywords
This publication has 34 references indexed in Scilit:
- Elevated energy expenditure in cancer patients with solid tumoursEuropean Journal of Cancer and Clinical Oncology, 1991
- INFLUENCE OF WHOLE-BODY PROTEIN-TURNOVER RATE ON RESTING ENERGY-EXPENDITURE IN PATIENTS WITH CANCER1988
- Induction of rat acute‐phase proteins by interleukin 6 in vivoEuropean Journal of Immunology, 1988
- Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.The Journal of Experimental Medicine, 1988
- Tumour necrosis factor in man: Clinical and biological observationsBritish Journal of Cancer, 1987
- Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas.1987
- Tumors secreting human TNF/cachectin induce cachexia in miceCell, 1987
- Interleukin 1, tumour necrosis factor‐alpha (cachectin) and the pathogenesis of cancer cachexiaClinical Physiology and Functional Imaging, 1987
- The Relationship Between Resting Energy Expenditure and Weight Loss in Benign and Malignant DiseaseAnnals of Surgery, 1986
- CANCER CACHEXIA AND PROTEIN METABOLISMThe Lancet, 1984